Form D · Pharmaceuticals

Tarrytown Co-Investment Holdings, LLC

Chicago, IL · CIK 0001797503

Offering snapshot reported Dec 20, 2019 · SEC filing

Reported sold
$6.33M
Offering amount: $6.33M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 11, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 20, 2019Initial$6,333,000No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b, 3C, 3C.1
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-356173

Source: Form D, filed Dec 20, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

TARRYTOWN CO-INVESTMENT HOLDINGS LLC

Investment adviser: PROMUS ASSET MANAGEMENT, LLC

Gross asset value
$816K
Beneficial owners
29
ADV minimum commitment
$150K

Reported in Form ADV on Apr 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor PLANTE & MORAN, PLLC CHICAGO, Illinois, United States
Custodian HINSDALE BANK & TRUST COMPANY, N.A. HINSDALE, Illinois, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

PLANTE & MORAN, PLLC
PCAOB 166

HINSDALE BANK & TRUST COMPANY, N.A.
LEI 9LIMABRJ9VPV74PBJB17

Filing source

Form ADV 2101476 · Apr 30, 2026 · Schedule D 7.B.(1), fund 805-4188657518

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Equity Partners, Llc Promus Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
156 North Jefferson Suite 300
Chicago, IL, 60661